⌘K

Login Start Free

Home/Filings/4/0001104659-23-000327

4//SEC Filing

Berrey M Michelle 4

Accession 0001104659-23-000327

CIK 0001270073other

View on SEC.gov Company Profile

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 4:01 PM ET

Size

4.8 KB

Accession

0001104659-23-000327

Insider Transaction Report

Form 4

Period: 2022-12-31

INTERCEPT PHARMACEUTICALS, INC.ICPT

Berrey M Michelle

President, R&D and CMO

Transactions

Tax Payment
Common Stock
2022-12-31$12.37/sh−765$9,463→ 69,177 total

Footnotes (1)

[F1]Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of restricted stock unit awards previously granted to the reporting person.

Documents

1 file

4
tm231319d1_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

INTERCEPT PHARMACEUTICALS, INC.

CIK 0001270073

Entity typeother

Related Parties

1

filerCIK 0001397329

Filing Metadata

Form type: 4
Filed: Jan 2, 7:00 PM ET
Accepted: Jan 3, 4:01 PM ET
Size: 4.8 KB

View on SEC.gov